We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

13:HKEXIndustrial and Commercial Bank of China Limited Analysis

Data as of 2026-07-22 - not real-time

HK$6.96

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ICBC trades at HK$6.96, comfortably above its 20‑day (HK$6.71) and 50‑day (HK$6.82) moving averages, indicating short‑term momentum. The 14‑day RSI sits at 56, suggesting neither overbought nor oversold conditions. MACD shows a bullish crossover (line positive, histogram +0.05) reinforcing upward bias. The stock is priced near the mid‑range of its 52‑week band, with support at HK$6.29 and resistance at HK$7.14. Volatility over the past 30 days is high at ~29%, but beta is very low (≈0.1‑0.36), implying limited market‑wide swings. The technical upside potential of ~19.6% aligns with analyst target median of HK$8.46.
Valuation is compelling: trailing PE of 6 versus industry average of 17.8 and price‑to‑book of 0.54. Dividend yield of 4.99% with a 30% payout ratio points to sustainable cash returns given the HK$4 trillion cash pile. Revenue is growing modestly (3.4% YoY) and profitability remains strong (profit margin 55%). However, operating cash flow is negative, flagging a short‑term cash conversion issue. Regulatory scrutiny in China and the bank’s massive debt load add medium‑level risk, yet the firm’s scale and low beta keep overall risk moderate. The consensus “strong buy” from 16 analysts and a 19% upside estimate support a buying case across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover
  • Price trading above short‑term moving averages
  • High dividend yield of 4.99%

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap (PE 6 vs industry 17.8)
  • Analyst target median price implies ~19% upside
  • Sustainable dividend with 30% payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Massive cash reserves and low beta provide stability
  • Potential regulatory and macro‑economic headwinds
  • Consistent dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth3.40%
Profit Margin55.15%
P/E Ratio6.0
ROE8.89%
ROA0.70%
P/B Ratio0.5
Op. Cash FlowHK$-73994002432
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI56.3
SupportHK$6.29
ResistanceHK$7.14
MA 20HK$6.71
MA 50HK$6.82
MA 200HK$6.49
MACDBullish
VolumeDecreasing
Fear & Greed Index90.98

Valuation

Target PriceHK$8.33
Upside/Downside19.62%
GradeUndervalued
TypeValue
Dividend Yield4.99%

Risk Assessment

Beta0.36
Volatility29.22%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.